| Verified against primary record | |
| Prior authorisation system | None[1] |
|---|---|
| Reimbursement requests (2023) | 4,448 received; granted and refused counts not reportable[1] |
| Unit of measurement | Treatment solutions, not persons or applications[1] |
| Scope of the Finnish figures | Include claims under national law for illness contracted outside the EU[1] |
| Average processing time | 99 days, with no statutory time limit[1] |
| National contact point | Kela, the social insurance institution[2] |
| Independently reported | |
| EU patients using the Directive each year | About 200,000, under 0.05 per cent of EU citizens[3] |
| Bands apply only to the rows beneath them. Finland is the only country in the collection that could report no outcomes at all, because its statistics count treatment decisions rather than people or applications. The 4,448 figure therefore cannot be read as a number of patients, and it includes claims arising under Finnish national law for illness contracted outside the European Union, which are not cross-border care under the Directive. No typical cost range is given because no official Finnish source publishes prices paid by foreign patients. | |
Medical tourism in Finland provides the clearest single illustration in European data of how a unit of measurement can defeat a statistic. Finland compiles its cross-border healthcare figures as treatment solutions rather than as persons or applications, and as a result it was unable to report how many claims it granted or refused in reference year 2023. The 4,448 requests it did report also include cases that are not cross-border care under the Directive at all.
A country that cannot report outcomes
The European Commission records that Finland compiles statistics on treatment solutions, not on persons or applications, and that it could not therefore report granted or refused counts. Finland is alone among the reporting countries in this respect: every other state that submitted data supplied at least some outcome figures.[1]
The distinction matters in both directions. A single patient may generate several decisions over a course of treatment, so a count of decisions overstates the number of people. Equally, a decision may cover more than one episode. Without a stated relationship between decisions and patients, the 4,448 figure cannot be converted into either.[1]
Finland also has no prior authorisation system, which places it with Estonia, Sweden, Norway, Cyprus, Lithuania and Latvia among the states that declined a power the Directive permits but does not require.[1]
What the Finnish figures include
The Commission records that the Finnish figures include claims made under national law for illness contracted outside the European Union. Those are not cases under Directive 2011/24/EU, which governs care obtained in another member state, so the Finnish total mixes two legally distinct categories.[1]
Finland also reimburses planned care in Switzerland, a non-member state to which the Directive does not apply, and the report records seven requests relating to Switzerland and three to the United Kingdom. These are small numbers, but they confirm that the Finnish series is built on national entitlement rules rather than on the Directive’s geographic scope.[1]
Processing is slow and unbounded. Finland reported an average of 99 days to settle a claim, and the report records that it operates no statutory time limit at all, which distinguishes it from every country in the collection that exceeded a deadline, since Finland has none to exceed.[1]
The framework
Finland’s designated national contact point for cross-border healthcare is Kela, the social insurance institution that administers statutory benefits.[2]
Under Directive 2011/24/EU the member state of affiliation must reimburse cross-border care where the treatment is among the benefits it covers domestically, capped at the level of costs it would have assumed and not exceeding the actual cost of the care received. Prior authorisation may be required only for care subject to planning requirements involving an overnight hospital stay or highly specialised and cost-intensive infrastructure, for treatments carrying a particular risk, and for providers raising serious quality or safety concerns.[5]
Eurostat separately maintains a collection of hospital discharges of non-residents, with tables for in-patients, day cases, bed days and average length of stay, reporting country of residence where member states can supply it. Individual cell values for Finland were not retrievable for this article.[4]
For scale, the European Court of Auditors estimated about 200,000 patients a year using the Directive across the Union, fewer than 0.05 per cent of EU citizens, and found that fewer than 20 per cent of citizens surveyed in 2015 were aware of their cross-border healthcare rights.[3]
Limits of the evidence
Almost nothing in this entry can be converted into patients. The single Finnish volume figure counts decisions, mixes Directive and national-law cases, and includes care in countries the Directive does not cover, while the outcome of those decisions is not reported at all. These figures also describe Finnish patients obtaining care abroad, not foreign patients treated in Finland, for which no official Finnish count was located. Finnish residents travelling to Estonia for private dental and elective treatment, a long-established flow across the Gulf of Finland, appears in none of these sources and has not been estimated.
See also
- Medical tourism in Estonia, the nearby destination for Finnish private medical travel
- International patient visits and unique patients, the distinction the Finnish unit of measurement loses
- Medical tourism statistics, and how a unit of measurement can defeat a figure
- Medical tourism in Switzerland, outside the Directive but inside Finland’s reimbursement rules
- Administrative data in medical tourism research, and the limits of decision-based counting
References
- European Commission, Directorate-General for Health and Food Safety. Data on cross-border patient healthcare following Directive 2011/24/EU, reference year 2023. 15 May 2025. Verified against primary record: the report was opened and the record that Finland has no prior authorisation system, the Finnish row showing 4,448 requests received with granted and refused counts unavailable, the statement that Finland compiles statistics on treatment solutions rather than persons or applications, the note that its figures include claims under national law for illness contracted outside the EU, the records of requests relating to Switzerland and the United Kingdom, and the 99-day average processing time with no time limit were read directly. Retrieved 23 October 2026.
- United Kingdom government publishing service. EEA countries and contact points. Verified against primary record: the list was opened and the designation of Kela as Finland’s national contact point was read directly. The document does not state a publication date, which is recorded here as a limitation. Retrieved 23 October 2026.
- European Court of Auditors. Special Report 07/2019: EU actions for cross-border healthcare. 2019. Verified against primary record: the report was opened and the annual patient estimate, the share of EU citizens and the 2015 awareness finding were read. Retrieved 23 October 2026.
- Eurostat. Hospital discharges and length of stay for inpatient and curative care (hlth_hosd), reference metadata. Last updated 15 December 2025. Verified against primary record: the metadata page was opened and the non-resident definition, the statement that country of residence is reported, and the list of non-resident tables were read. Retrieved 23 October 2026.
- European Parliament and Council. Directive 2011/24/EU, Chapter III, Articles 7 and 8. 9 March 2011. Verified against primary record: the chapter text was opened and the reimbursement rule in Article 7, its application to care obtained in another member state, and the three permitted grounds for prior authorisation in Article 8(2) were read. Retrieved 23 October 2026.
Sourcing note: this entry uses only official sources. The 4,448 figure is deliberately not converted into a number of patients, because the Commission records that Finland counts treatment decisions and gives no relationship between decisions and people. The inclusion of national-law cases and of care in non-member states is reported because it means the Finnish total is not comparable with other countries’ Directive figures. No official Finnish count of foreign patients treated in Finland was located, and no figure has been estimated.